Comparing two endoscopic treatments for small rectal neuroendocrine tumors
Part of Cancer, Digestive system clinical trials.
This study compares two minimally invasive endoscopic techniques—ESD and EPMR—for removing small neuroendocrine tumors (slow-growing hormone-producing tumors) in the rectum. The goal is to see which approach works better and is safer for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a rectal neuroendocrine tumor (a slow-growing tumor in the rectum) diagnosed and scheduled for endoscopic removal
- Your tumor is smaller than 2 centimeters (about the size of a small bean)
- Imaging tests show no cancer spread to nearby lymph nodes or distant organs
- Your doctor plans to remove the tumor using either ESD (endoscopic submucosal dissection) or EPMR (endoscopic full-thickness resection)—two specific minimally invasive techniques
- You are willing to participate and your family supports your involvement
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of removing very small rectal neuroendocrine tumors (less than 1 cm): a modified technique using a special snare (mDS-EMR) versus a more involved removal called ESD. Both are done through a scope (endoscopy) without major surgery.
This study compares two minimally invasive ways to remove small rectal neuroendocrine tumors (NETs), which are growths in the rectum that are usually not cancer. The goal is to find which method is safer and more effective with fewer side effects.
This trial tests whether using a special traction device during endoscopic removal of small rectal neuroendocrine tumors is safer or more effective than the standard method. It may help patients with these tumors have a less invasive treatment.
This study is testing whether a minimally invasive endoscopic procedure (using a scope through the anus) can safely remove small rectal neuroendocrine tumors. If you're eligible, this could be a less invasive way to treat your condition without major surgery.
This trial studies two ways to remove small rectal neuroendocrine tumors (slow-growing tumors in the rectum) using an endoscope. It aims to see which method works better and if it can be done safely and effectively without more invasive surgery.
This study compares two minimally invasive procedures to remove large, non-cancerous or early-stage growths in the rectum. The goal is to see if one method is safer or more effective, which may help you avoid more invasive surgery.
Hear when a new Rectal Neuroendocrine Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.